Low-Dose DOAC Valuable in Afib After Age 80

(MedPage Today) -- A low dose of the direct oral anticoagulant (DOAC) edoxaban (Savaysa) reduced thrombotic events in elderly atrial fibrillation patients without a significant excess in bleeding, a Japanese trial showed.
Among such patients ages...